Libo Chen
Impact in
- Immunology top 10%
- Galectins and Cancer Biology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Hepatology top 5%
Papers in ⓘ
-
- Epigenetics and DNA Methylation 4
- Surgery 11
- Co-authors
- Guobin Wang (6 shared papers)Ke Wu (2 shared papers)Kaixiong Tao (1 shared paper)Jun Liu (1 shared paper)Weiping Zou (1 shared paper)Liang Shi (1 shared paper)Qichang Zheng (1 shared paper)Xiaoming Lu (1 shared paper)
- Journals
- Toxics (2 papers)Phytotherapy Research (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)International Journal of Urology (1 paper)Journal of Hazardous Materials (1 paper)
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Libo Chen
50 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 88
- Immunology 376
- Hepatology 127
- Genetics 153
- Oncology 372
- Cancer Research 196
Countries citing papers authored by Libo Chen
This map shows the geographic impact of Libo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Chen more than expected).
Fields of papers citing papers by Libo Chen
This network shows the impact of papers produced by Libo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Chen. The network helps show where Libo Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 405 | |
| 2 | 2004 | 232 | |
| 3 | 2010 | 82 | |
| 4 | 2016 | 81 | |
| 5 | 2021 | 47 | |
| 6 | Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene. | 2006 | 42 |
| 7 | 2011 | 32 | |
| 8 | 2008 | 31 | |
| 9 | 2021 | 24 | |
| 10 | 2012 | 24 | |
| 11 | 2021 | 21 | |
| 12 | 2006 | 20 | |
| 13 | 2003 | 20 | |
| 14 | 2001 | 18 | |
| 15 | 2020 | 15 | |
| 16 | 2001 | 15 | |
| 17 | 2010 | 14 | |
| 18 | 2017 | 14 | |
| 19 | 2009 | 13 | |
| 20 | 2021 | 12 |
About Libo Chen
Libo Chen is a scholar working on Molecular Biology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer Research and Treatments (4 papers), Cell Adhesion Molecules Research (4 papers), MicroRNA in disease regulation (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer-related molecular mechanisms research (4 papers), Sarcoma Diagnosis and Treatment (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Immunology (376 citations), Hepatology (127 citations), Genetics (153 citations), Oncology (372 citations) and Cancer Research (196 citations). Libo Chen has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Guobin Wang, Ke Wu, Kaixiong Tao, Jun Liu, Weiping Zou, Liang Shi, Qichang Zheng, Xiaoming Lu, Hang Li and Lian Yang. Their work appears in journals such as Toxics, Phytotherapy Research, Bioorganic & Medicinal Chemistry Letters, International Journal of Urology and Journal of Hazardous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.